| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | CMK | GDSC1000 | pan-cancer | AAC | -0.0094 | 0.9 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.0078 | 0.9 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | 0.03 | 0.9 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.007 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | -0.005 | 0.9 |